[EN] ENTPD5 INHIBITORS<br/>[FR] INHIBITEURS DE ENTPD5
申请人:UNIV TEXAS
公开号:WO2012065139A2
公开(公告)日:2012-05-18
The invention provides methods and pharmaceutical compositions for treating cancer or promoting apoptosis of cancer cells, or reducing the resistance of cancer cells to chemotherapy or apoptosis-promoting therapies by contacting the cancer cells with an ENTPD5-specific inhibitor.
Novel Derivatives of Nitrobenzofurazan with Chromogenic and Fluorogenic Properties
作者:Alexandru Bujor、Anamaria Hanganu、Rodica Baratoiu、Elena N. Hristea、Madalina Tudose、Victorita Tecuceanu、Augustin M. Madalan、Petre Ionita
DOI:10.3390/molecules28166146
日期:——
Five newderivatives were obtained utilizing 4-chloro-7-nitrobenzofurazan (NBD-chloride) in combination with furfurylamine, adamantylamine, aminohippuric acid, phenylalanine, and dehydroabietylamine. These derivatives were then subjected to a comparative analysis of their physical, chemical, and certain biological properties alongside two analogous and known compounds derived from the glycine and 4-amino-TEMPO